Associated Papers
Variable response of germline activating PDGFRB variants to receptor tyrosine kinase inhibitors: implications for treatment.
Cristea I et al.
European Journal of Human Genetics : Ejhg, 2025
Corneal Myofibromatous and Pterygium-Like Changes in a Family With a PDGFRB Variant.
Raber IM et al.
Cornea, 2025
Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.
Gudernova I et al.
Oncotarget, 2017
Corneal Infantile Myofibromatosis Caused by Novel Activating Imatinib-Responsive Variants in PDGFRB.
Howaldt A et al.
Ophthalmology Science, 0
Select a paper to view details